All In MedTech

Device Trial Radar · NCT02234128

Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility

A Phase 2, Multicenter, Open-label Study to Measure the Safety of Extending Preservation and Assessment Time of Donor Lungs Using Normothermic Ex Vivo Lung Perfusion and Ventilation (EVLP) as Administered by the SPONSOR Using the Toronto EVLP System™

Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

118

Actual

Start

Jul 18, 2015

Primary completion

Nov 21, 2018

Study completion Nov 7, 2019

Sponsor

Lead sponsor
Lung Bioengineering Inc.Not on our public-company list
Sponsor type
Industry
First posted
Sep 9, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a safety study to compare the safety of receiving a lung treated with the Toronto EVLP System™ by SPONSOR in SPONSOR's dedicated facility against standard lung transplantation.

Conditions

  • Lung Disease

Interventions

  • Toronto EVLP System™Device

    Extending preservation and assessment time of donor lungs using the Toronto EVLP System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Count of Participants With Primary Graft Dysfunction (PGD), Grade 3Time frame: 72 Hours
  2. Count of Participants SurvivingTime frame: 30 Days

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic Jacksonville

    Jacksonville, Florida

  • Loyola University Medical Center

    Chicago, Illinois

  • University of Maryland Medical Center

    Baltimore, Maryland

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.